Morepen Laboratories

Price chart

Previous close

₹94.43

Open

₹93.50

Day high

₹99.15

Day low

₹93.50

Listed on NSE since 24 November 1999.

Market value

₹5,174.33 Cr

P/E (trailing)

27.53

EPS (trailing)

₹3.43

Price to book

3.75

Dividend yield

0.22%

Return on equity

14.6%

Debt to equity

0.23

Profit margin

8.2%

Beta

0.95

Volume today

61.29 L

Average volume

1.74 Cr

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Morepen Laboratories’s results filed with NSE, consolidated (the whole group). Net profit is the share of Morepen Laboratories’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Morepen Laboratories’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, NASH/ MASH treatment products, CKD treatment, and anti-depressant drugs; and home diagnostic and point-of-care medical devices products, such as blood glucose monitor and test strips, blood pressure monitors, respiratory devices, ortho support, digital thermometers, digital weighing scale, fertility, nebulizers, pulse oximeters, vaporizers, orthopaedic, stethoscope, and miscellaneous products. It also provides OTC healthcare products; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. In addition, the company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Gurugram

Employees

1,919

Company website · Profile: Yahoo Finance

No headlines name Morepen Laboratories in the last day or two.

• Dividend - Re 0.20 Per Share

  Dividend · ex-date 18 September 2026 · record date 19 September 2026

• Dividend - Re 0.20 Per Share

  Dividend · ex-date 29 August 2025 · record date 30 August 2025

• Annual General Meeting

  Action · ex-date 20 September 2024

• Annual General Meeting

  Action · ex-date 21 September 2023

• Annual General Meeting

  Action · ex-date 19 September 2022

• Annual General Meeting

  Action · ex-date 20 September 2021

• Annual General Meeting

  Action · ex-date 22 September 2020

• Annual General Meeting

  Action · ex-date 5 September 2019

Source: NSE. Latest first, 8 of 20.